As usual, the one-two punch of ASCO and BIO set us a bit behind, but never fear – your June hires round-up is here at least ...

The major LLMs today are legal landmines, providing no visibility into training data that may violate copyrights, patents, ...

New research from the Wharton School’s Generative  AI Labs shows how large language models can be coaxed into ignoring safety ...

The Food and Drug Administration has granted permission for Juul to continue selling its e-cigarettes, offering some reprieve ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

For Stephen Yeager, who owns a Theodore company that helps lawyers with digital forensics, research and jury consulting, artificial intelligence has been a “game-changer.” But there are potential ...

The UK now has one of the most energy-efficient supercomputers in the world, with the unveiling of the new Isambard-AI ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...